The Alteration of Plasma Matrix Metalloproteinase-9 Level after the Addition of Bromelin 500 mg to Standard Therapy of Acute Ischemic Stroke and Its Correlation with Outcome

BACKGROUND: Matrix metalloproteinase-9 (MMP9) expression due to ischemic cause spreading of brain damage. Previous studies have reported that Bromelin was beneficial as anti-inflammation and prevent brain tissue damage. AIM: This study aimed to determine the alteration of plasma MMP9 level after add...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinurat, Puji Pinta, Sjahrir, Hasan, Rambe, Aldy S., Ganie, Ratna Akbari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Republic of Macedonia 2018
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927490/
https://www.ncbi.nlm.nih.gov/pubmed/29731927
http://dx.doi.org/10.3889/oamjms.2018.151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927490/
https://www.ncbi.nlm.nih.gov/pubmed/29731927
http://dx.doi.org/10.3889/oamjms.2018.151

Ejemplares similares